In fact, Thymosin Beta-4 has been tested topically in clinical trials regarding its potential for skin and corneal healing [12]
That gap in supply has given a boost to compounding pharmacies (who are allowed to produce customized versions of drugs, OR identical versions of drugs that are in short supply i) and online prescribing platforms
Rebuilds what keeps skin firm GHK-Cu activates fibroblasts, the cells that make collagen and elastin, the proteins behind firmness and bounce
The failure of broader or less specific agents, therefore, reinforces the central theme that therapeutic success in MIRI demands a highly targeted approach that addresses the specific downstream consequences of the initial oxidative insult
Metabolic support: Trials show improved triglycerides and inflammatory markers such as CRP, with muscle mass preserved during treatment (Brown & Glesby, 2023)